Outcomes of Clareon PanOptix Pro in Patients With Prior Myopic Refractive Surgery

Exclusion Criteria

• •Any ocular comorbidity that might hamper postoperative visual acuity:
• •* Corneal abnormality including corneal dystrophy, irregularity, and degeneration.
• •* Moderate or severe dry eyes that can't be relieved after treatment.
• •* History of or current anterior and posterior inflammation of any etiology.
• •* Retinal pathology such as AMD, diabetic retinopathy, vein occlusion, etc.
• •* Glaucoma of any kind.
• •* Pregnancy or lactation.
• •Any ocular surgery other than corneal myopic refractive surgery (LASIK and PRK).
• •Patients with physical or intellectual disability (e.g. Down's Syndrome, Parkinson's Disease, unable to fixate)
• •Apple Kappa/chord mu ≥ 0.6.
• •Higher order corneal aberrations at pupil diameter of 4mm: \> 0.6 total RMS, \> 0.3 coma, \> 0.3 trefoil (to exclude irregular corneas)
• •Any patient requiring a limbal relaxing incision.
• •The principal investigator reserves the right to declare a patient ineligible or non-evaluable based on medical evidence that indicates they are unsuitable for the trial.